吳 明恒

Medicine & Life Sciences

1. Galectin 1 100%
2. Neuropilin-1 56%
3. Hepatocellular Carcinoma 27%
4. Androgen Receptors 24%
5. Epithelial-Mesenchymal Transition 23%
6. Neoplasm Metastasis 22%
7. Squamous Cell Carcinoma 21%
8. Neoplasms 20%
9. Berberine 20%
10. HSP90 Heat-Shock Proteins 19%
11. Colorectal Neoplasms 18%
12. Cell Movement 17%
13. 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 16%
14. Glycosylation 15%
15. Cancer-Associated Fibroblasts 13%
16. glycidamide 13%
17. AT-Hook Motifs 12%
18. Carcinoma 12%
19. Prostatic Neoplasms 12%
20. NADPH Oxidase 4 11%
21. Fibroblasts 11%
22. Vascular Endothelial Growth Factor Receptor-1 11%
23. Sorafenib 11%
24. Anoikis 10%
25. RNA 10%
26. RNA Isoforms 10%
27. Growth 10%
28. Somatomedin Receptors 9%
29. Myofibroblasts 9%
30. Protein Stability 9%
31. Vascular Endothelial Growth Factor Receptor-2 9%
32. Cell Cycle Proteins 9%
33. Mouth Neoplasms 9%
34. Platelet-Derived Growth Factor 8%
35. Tumor Necrosis Factor Receptors 8%
36. Tumor Microenvironment 8%
37. Carcinoembryonic Antigen 8%
38. Cell Adhesion Molecules 8%
39. Capillary Permeability 8%
40. Long Noncoding RNA 8%
41. Proteins 8%
42. Transforming Growth Factors 7%
43. Endometrial Neoplasms 7%
44. Liver Cirrhosis 7%
45. Down-Regulation 7%
46. Actin Cytoskeleton 7%
47. Wound Healing 7%
48. Hepatitis B virus 7%
49. Matrix Metalloproteinases 7%